These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11873119)

  • 21. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir.
    Bernardeschi C; Valeyrie-Allanore L; Ortonne N; Gressier L; Wallet-Faber N; Bernard PH; Hezode C; Duclos-Vallée JC; Samuel D; Mallet V; Pol S; Milpied B; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):143-6. PubMed ID: 25187266
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of chronic hepatitis B in children.
    Bortolotti F
    J Hepatol; 2003; 39 Suppl 1():S200-5. PubMed ID: 14708704
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy of chronic viral hepatitis.
    Fried MW
    Med Clin North Am; 1996 Sep; 80(5):957-72. PubMed ID: 8804370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-induced central retinal vein thrombosis.
    Nazir L; Husain A; Haroon W; Shaikh MI; Mirza SA; Khan Z
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):735-6. PubMed ID: 23146860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hepatitis C: therapeutic management].
    Bourliere M
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy.
    Widjaja A; Wedemeyer H; Tillmann HL; Horn R; Ockenga J; Jaeckel E; von zur Mühlen A; Manns MP; Brabant G
    Scand J Gastroenterol; 2001 Apr; 36(4):426-31. PubMed ID: 11336170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon therapy.
    Williams CN
    Can J Gastroenterol; 1997 Oct; 11(7):563-4. PubMed ID: 9395755
    [No Abstract]   [Full Text] [Related]  

  • 29. Expert recommendations on the application of interferon for chronic hepatitis B.
    Wan MB; Weng XH
    J Dig Dis; 2013 Dec; 14(12):626-37. PubMed ID: 23981279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on Fabrizi et al.: Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies.
    Pan YN; Luo YJ; He S
    J Med Virol; 2015 Aug; 87(8):1255. PubMed ID: 26037651
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
    Degos F; Marcellin P; Benhamou JP
    Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of interferon therapy on heart rate and sympathetic nervous system.
    Yamamoto T; Tsuchihashi T; Hayashi J; Kashiwagi S
    Fukuoka Igaku Zasshi; 1998 Jul; 89(7):207-15. PubMed ID: 9745188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current treatment of chronic hepatitis B].
    Rodríguez M; Pérez R
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():51-7. PubMed ID: 11279894
    [No Abstract]   [Full Text] [Related]  

  • 34. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply to the letter by Pan Yanna et al. 'treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies'.
    Fabrizi F; Messa P; Martin P
    J Med Virol; 2015 Aug; 87(8):1256-7. PubMed ID: 26037652
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon therapy for chronic HCV hepatitis: trick or treat?
    Malnick SD; Schmilovitz-Weiss H
    J Clin Gastroenterol; 1997 Jul; 25(1):310-3. PubMed ID: 9412909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
    Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP
    Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis B virus and celiac disease].
    Narváez Rodríguez I; Jiménez Jaén C
    Gastroenterol Hepatol; 2010 Oct; 33(8):617. PubMed ID: 20434813
    [No Abstract]   [Full Text] [Related]  

  • 39. Current treatment for chronic hepatitis C.
    Davis GL
    Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmological complications in hepatitis C virus infection: side effect of interferon therapy or a direct role of HCV?
    Pazienza V
    Biomed Pharmacother; 2011 Jul; 65(4):317-8. PubMed ID: 21705184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.